ABVC BioPharma, Inc. (ABVC)
1.41
0.00 (0.00%)
USD |
NASDAQ |
May 29, 16:00
1.405
0.00 (0.00%)
After-Hours: 20:00
ABVC BioPharma Shareholders Equity (Quarterly) : 10.77M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 133.90M |
| Perspective Therapeutics, Inc. | 347.44M |
| MiMedx Group, Inc. | 242.94M |
| Abbott Laboratories | 52.06B |
| AngioDynamics, Inc. | 173.36M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.73M |
| Total Liabilities (Quarterly) | 6.904M |
| Debt to Equity Ratio | 0.2535 |
| Current Ratio | 0.1203 |
| Net Debt Paydown Yield | 0.39% |